Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
Quick Stats
Feb 02, 202652.0
AI Score
HOLD0.19
Volume Ratio
Mar 25, 2026
Next Earnings
12
+ve Days (30d)
15
-ve Days (30d)
MREO Stock Summary
Last updated Feb 02, 2026
MREO is currently trading at $0.4325, positioned below its 200-day moving average of $1.89, suggesting bearish momentum. The stock has a 52-week range of $0.2 to $3.255.
Technical Analysis: The 50-day moving average stands at $1.29, which is above the current price, indicating bearish near-term pressure. The RSI (Relative Strength Index) reads 30.412, suggesting the stock is neutral with balanced momentum.
Money Flow Indicators: The Chaikin Money Flow (20-day) is -0.105, which is negative, suggesting distribution or selling pressure. Our AI-powered investment score rates MREO at 52.0/100 with a HOLD recommendation.
MREO (Mereo BioPharma Group plc American Depositary Shares) Indicators
Last updated Feb 02, 2026
| Indicator | Value |
|---|---|
| RSI(14) | 30.412 |
| CMF (20) | -0.105 |
| ROC (10) | -32.422 |
| ADX (14) | 34.551 |
| Indicator | Value |
|---|---|
| MACD (12,26,9) | -0.23 |
| AROONOSC (14) | -85.714 |
| WILLAMS %R (14) | -93.919 |
| MFI (14) | 48.685 |
MREO Technical Chart
- Candlesticks: Green = price up, Red = price down. Body shows open/close, wicks show high/low.
- SMAs: Moving averages help identify trends. Price above SMA = bullish, below = bearish.
- Options OI: Shows max open interest strikes. High OI = significant price levels.
- Volume Profile: Shows price levels with most trading activity. POC = Point of Control (highest volume).
- Earnings: Vertical lines mark earnings dates. Watch for volatility around these dates.
- Gamma Walls: Key support/resistance from options gamma exposure. Orange = resistance above, Purple = support below.
- Fibonacci Retracement: Auto-calculated support/resistance levels based on recent high/low. Key levels: 23.6%, 38.2%, 50%, 61.8%, 78.6%.
- Unusual Activity: Highlights days with abnormal volume (2x+ average) or large price moves (5%+). Red marker = unusual activity detected.
Technical Indicators
Select indicators above to analyze technical patterns
Indicators will appear below the price chart with perfectly aligned datesVolume Profile Analysis
Horizontal histogram showing volume distribution at each price level with buying/selling pressure
MREO Price vs Max Options Open Interest
MREO Max Change In Options Open Interest
MREO Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MREO Daily Out of Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MREO Daily In the Money Options - Sort by Max open Interest (near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | OI | Change in OI |
Volume | Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
MREO Most Active Options by Volume(near term)
3rd February 2026 (Data is delayed in normal mkt. hours)
| Type | Expiration | Strike | Volume | OI | Change in OI |
Ask | PC | Delta | Vega | Volatility | % change | Track |
|---|
Mereo BioPharma Group plc American Depositary Shares is not trading above both 50 Day and 200 Day SMA which is considered Bearish.
MREO Moving Averages Analysis
MREO (Mereo BioPharma Group plc American Depositary Shares) Simple Moving Averages
Moving Averages are last updated Feb 02, 2026
| Days | MA |
|---|---|
| 10 | 0.49 |
| 20 | 0.52 |
| 30 | 0.83 |
| 50 | 1.29 |
| 100 | 1.6 |
| 200 | 1.89 |
MREO Fundamental Analysis
| P/E (Forward) | 0 |
| P/E (Trailing) | -- |
| Market Cap ($) | 70.0 million |
| Earnings/Share ($) | -0.25 |
| Net Proft Margin (%) | 0 |
| Dividend/Share ($) | -- |
| EPS Estimate Current Year ($) | -0.0447 |
| EPS Estimate Next Year ($) | -0.0236 |
| WallStreet Target Price ($) | 2.6887 |
| Most Recent Quarter |